Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss

A Fontalis, E Kenanidis, RA Kotronias… - Expert Opinion on …, 2019 - Taylor & Francis
Introduction: Pharmacological options to address the imbalance between bone resorption
and accrual in osteoporosis include anti-resorptive and osteoanabolic agents. Unique …
被引用次数：41 相关文章

Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss

A Fontalis, E Kenanidis… - Expert opinion on …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction Pharmacological options to address the imbalance between bone resorption
and accrual in osteoporosis include anti-resorptive and osteoanabolic agents. Unique …

Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss.

A Fontalis, E Kenanidis, RA Kotronias… - Expert Opinion on …, 2019 - eprints.whiterose.ac.uk
INTRODUCTION: Pharmacological options to address the imbalance between bone
resorption and accrual in osteoporosis include anti-resorptive and osteoanabolic agents …
[PDF] potoupnis.gr

[PDF][PDF] Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss

A Fontalis, E Kenanidis, RA Kotronias, A Papachristou… - 2019 - potoupnis.gr
Introduction: Pharmacological options to address the imbalance between bone resorption
and accrual in osteoporosis include anti-resorptive and osteoanabolic agents. Unique …
[PDF] core.ac.uk

[PDF][PDF] Current and emerging osteoporosis pharmacotherapy for women: state-of-the-art therapies for preventing bone loss.

A Fontalis, E Kenanidis, RA Kotronias, A Papachristou… - core.ac.uk
Introduction: Pharmacological options to address the imbalance between bone resorption
and accrual in osteoporosis include anti-resorptive and osteoanabolic agents. Unique …

Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss.

A Fontalis, E Kenanidis, RA Kotronias… - Expert Opinion on …, 2019 - europepmc.org
Pharmacological options to address the imbalance between bone resorption and accrual in
osteoporosis include anti-resorptive and osteoanabolic agents. Unique biologic pathways …